Latest Articles

Publication Date
C57BL/6J mice best recapitulate fibrosis and inflammatory pathophysiology in syngeneic mouse model of endometriosis.

Endometriosis (ENDO), a chronic inflammatory disease affecting approximately 190 million women globally, is characterized by fibrosis, a feature often challenging to replicate in murine models. To identify an optimal syngeneic …

Published: Aug. 8, 2025, midnight
Effects of Mono- (2-ethylhexyl) phthalate and Phthalic Acid Monobenzyl Ester on endometriosis using network toxicology, machine learning and molecular docking techniques.

Phthalate metabolites Mono- (2-ethylhexyl) phthalate(MEHP) and Phthalic Acid Monobenzyl Ester (MBZP) are widely present in the environment, can interfere with the endocrine system and accumulate in human tissues, and are …

Published: Aug. 8, 2025, midnight
Artificial intelligence-driven decision tree model for predicting quality of life determinants in women with endometriosis.

Endometriosis significantly impacts the quality of life (QoL) of affected women due to its complex symptomatology. This study aimed to develop a decision tree-based model to identify the key determinants …

Published: Aug. 8, 2025, midnight
Dietary and lifestyle strategies for endometrial cancer prevention: Emerging evidence and unanswered questions - EurekAlert!

Dietary and lifestyle strategies for endometrial cancer prevention: Emerging evidence and unanswered questions EurekAlert!

Published: Aug. 7, 2025, 3:02 p.m.
Immunotherapy plus chemotherapy approved for endometrial cancer - The Pharmaceutical Journal

Immunotherapy plus chemotherapy approved for endometrial cancer The Pharmaceutical Journal

Published: Aug. 7, 2025, 2:48 p.m.
Breakthrough treatment combines immunotherapy and chemotherapy - National Health Executive

Breakthrough treatment combines immunotherapy and chemotherapy National Health Executive

Published: Aug. 7, 2025, 8:48 a.m.
Toxicity and Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer: A Real-World Retrospective Analysis - Frontiers

Toxicity and Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer: A Real-World Retrospective Analysis Frontiers

Published: Aug. 7, 2025, 7:56 a.m.
Ovum Launches with $1.7M Funding to Develop AI-Powered Women’s Health Platform - Femtech Insider

Ovum Launches with $1.7M Funding to Develop AI-Powered Women’s Health Platform Femtech Insider

Published: Aug. 7, 2025, 7:33 a.m.
Ovum Launches with $1.7m Funding to Develop AI-Powered Women’s Health Platform - Femtech Insider

Ovum Launches with $1.7m Funding to Develop AI-Powered Women’s Health Platform Femtech Insider

Published: Aug. 7, 2025, 7:08 a.m.
Predictors of Persistent Pain After Hysterectomy for Chronic Pelvic Pain: A Systematic Review.

To systematically review predictors associated with persistent pain after hysterectomy performed for individuals with chronic pelvic pain.

Published: Aug. 7, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!